CVE:HTL - Hamilton Thorne Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: C$2.33
  • Forecasted Upside: 59.25 %
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
C$1.46
▲ +0.03 (2.10%)

This chart shows the closing price for HTL by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Hamilton Thorne Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for HTL and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for HTL

Analyst Price Target is C$2.33
▲ +59.25% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Hamilton Thorne in the last 3 months. The average price target is C$2.33, with a high forecast of C$0.00 and a low forecast of C$0.00. The average price target represents a 59.25% upside from the last price of C$1.46.

This chart shows the closing price for HTL for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 2 contributing investment analysts is to buy stock in Hamilton Thorne. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/4/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/4/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
6/2/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/31/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/29/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/27/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/28/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/28/2022

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/22/2022Colliers SecuritiesReiterated RatingBuy
11/22/2021Echelon Wealth PartnersReiterated RatingBuy
7/19/2021CormarkBoost Price TargetC$2.10 ➝ C$2.25
7/16/2021Acumen CapitalBoost Price TargetC$2.15 ➝ C$2.40
5/26/2021Acumen CapitalBoost Price TargetC$2.00 ➝ C$2.15
5/26/2021Pi FinancialBoost Price TargetC$2.15 ➝ C$2.75
4/9/2021Pi FinancialBoost Price TargetC$1.80 ➝ C$2.15
4/9/2021Colliers SecuritiesBoost Price TargetC$1.50 ➝ C$1.60
2/2/2021Colliers SecuritiesReiterated RatingBuyC$1.93
11/20/2020Pi FinancialBoost Price TargetBuyC$1.70 ➝ C$1.80
8/25/2020CormarkBoost Price TargetC$1.40 ➝ C$1.70
8/21/2020Bloom BurtonReiterated RatingBuy
8/20/2020Pi FinancialSet Price TargetBuyC$1.60
6/12/2020Pi FinancialSet Price TargetBuyC$1.45
6/9/2020Eight CapitalSet Price TargetBuyC$1.80
6/2/2020Pi FinancialSet Price TargetBuyC$1.45
5/27/2020Pi FinancialReiterated RatingBuyC$1.45
4/29/2019Beacon SecuritiesReiterated RatingBuy
2/12/2019Acumen CapitalSet Price TargetBuyC$1.30
2/13/2018Beacon SecuritiesReiterated RatingBuy
10/25/2017Bloom BurtonReiterated RatingBuy
(Data available from 5/28/2017 forward)

News Sentiment Rating

0.44 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/30/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/29/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/29/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
1/28/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/27/2022
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/29/2022
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/28/2022
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
5/28/2022

Current Sentiment

  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Hamilton Thorne logo
Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets under the Hamilton Thorne brand; test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services under the Embryotech brand. The company also manufactures and distributes products for reproductive medicine, including clinical and laboratory equipment and disposables, as well as complete installations of ART clinics under the Gynemed brand; and bench top incubators, programmable freezers, loggers, alarms, cryo storage, and software systems and sensors for the safe preservation of medical and biological specimens used in ART and cell biology applications under the Planer brand. It sells its products and services through a direct sales force in the United States, Germany, France, and the United Kingdom, as well as through distributors to approximately 2,000 fertility clinics, hospitals, pharmaceutical companies, biotechnology companies, educational institutions, and other commercial and academic research establishments in approximately 75 countries. The company is headquartered in Beverly, Massachusetts.
Read More

Today's Range

Now: C$1.46
Low: C$1.41
High: C$1.46

50 Day Range

MA: C$1.74
Low: C$1.40
High: C$2.05

52 Week Range

Now: C$1.46
Low: C$1.39
High: C$2.20

Volume

468,530 shs

Average Volume

75,973 shs

Market Capitalization

C$209.06 million

P/E Ratio

81.11

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Hamilton Thorne?

The following Wall Street analysts have issued reports on Hamilton Thorne in the last twelve months: Acumen Capital, Colliers Securities, Cormark, and Echelon Wealth Partners.
View the latest analyst ratings for HTL.

What is the current price target for Hamilton Thorne?

0 Wall Street analysts have set twelve-month price targets for Hamilton Thorne in the last year. Their average twelve-month price target is C$2.33, suggesting a possible upside of 59.2%.
View the latest price targets for HTL.

What is the current consensus analyst rating for Hamilton Thorne?

Hamilton Thorne currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe HTL will outperform the market and that investors should add to their positions of Hamilton Thorne.
View the latest ratings for HTL.

How do I contact Hamilton Thorne's investor relations team?

Hamilton Thorne's physical mailing address is 100 Cummings Ctr Ste 465e, BEVERLY, MA 01915-6143, United States. The company's listed phone number is +1-978-9212050. The official website for Hamilton Thorne is www.hamiltonthorne.com. Learn More about contacing Hamilton Thorne investor relations.